International Stem Cell Corporation
ISCO
$0.40
$0.039.23%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 9.32% | 8.74% | -11.90% | 8.72% | 4.98% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.32% | 8.74% | -11.90% | 8.72% | 4.98% |
| Cost of Revenue | 31.28% | -3.83% | 7.68% | 7.60% | 1.53% |
| Gross Profit | -4.08% | 19.70% | -25.21% | 9.63% | 7.19% |
| SG&A Expenses | 3.02% | 19.74% | 10.93% | -3.52% | 0.42% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.99% | 6.87% | 3.05% | 0.26% | 4.49% |
| Operating Income | -54.49% | 11.63% | -713.73% | 204.44% | 12.08% |
| Income Before Tax | -155.04% | 14.06% | -3,263.64% | 145.60% | 8.40% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -155.04% | 14.06% | -3,263.64% | 145.60% | 8.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -155.04% | 14.06% | -3,263.64% | 145.60% | 8.40% |
| EBIT | -54.49% | 11.63% | -713.73% | 204.44% | 12.08% |
| EBITDA | -53.39% | 2.50% | -346.67% | 505.41% | 11.06% |
| EPS Basic | -205.95% | 14.06% | -3,207.14% | 123.08% | 9.09% |
| Normalized Basic EPS | -69.31% | 14.00% | -3,122.22% | 145.92% | 8.60% |
| EPS Diluted | -205.95% | 14.06% | -3,207.14% | 118.00% | 9.09% |
| Normalized Diluted EPS | -69.31% | 14.00% | -3,122.22% | 144.90% | 8.60% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 2.04% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |